Cryrian Defense Forces: Difference between revisions

Jump to navigation Jump to search
Line 697:
The modern Cryrian biological weapons program began shortly after the Great War in anticipation of a new conflict. At this time the Kingdom was in a state of growing domestic turmoil and had seen its military strength badly weakened by over a decade of continuous warfare. Its foreign influence was simultaneously collapsing with the the loss spheres of influence in Älemsi Negdel and Aikthudr'zhur. The end of the Tanznozhiv and the rise of the Volscine Confederation created a new and potentially dangerous power to the south, one which was now pressing demands against the Leidensen titles over Charlottesborg, which were ultimately ceded in 1923. The rise of militant leftist movements on the Mainland created further pressure on the Cryrian state to restore the means of military deterrence as quickly as possible.
 
Tomorrow Minister Folke Hägg was the first to propose building upon previous efforts at biological warfare to that end. Both Hägg and the eugenicists at the Tomorrow Ministry theorized that infectious strains capable of inflict damage on a civilizational scale could and would be developed in the near future by various nation states. This would, in essence, create a scenario of mutually assured destruction. While the Tomorrow Ministry's estimations were wildly incorrect, they did lead to the creation of a biological warfare section under the Special Materials Division which spearheaded far more legitimate and scientifically founded research into the topic. The isolatedIsolated and uninhabited island of Narsiislands in Tynam's wasSiggeholm usedGroup aswere aused for secretive testing, production, and storage sitefacilities. Research was also conducted throughoutunder the earlyguise 20thof centurylegitimate civil biotechnology efforts and involved several important Cryrian universities as well as the Ministry of Agriculture.
 
Cryrian efforts in this area progressed along two lines - One intended to attack enemy food supplies, particularly livestock, and another for sapient targets. The CDF did develop and test a line of "Anthrax bombs" that would be used to bread the disease across livestock.
The program soon began to face resistance from within the Special Materials Division itself, which reported that the weapons being developed were "Unlikely to offer any military value outside the realm of terror or desperation." Nonetheless, the powerful political support of the Tomorrow Ministry ensured that the program would continue to grow and develop until the White November Crisis of 1957. After the downfall of the Ministry, the Cryrian Government began to gradually shut the program down until it had been entirely dismantled in 1960.
 
The program soon began to face resistance from within the Special Materials Division itself, which reported that the weapons being developed were "Unlikely to offer any military value outside the realm of terror or desperation." Nonetheless, the powerful political support of the Tomorrow Ministry ensured that the program would continue to grow and develop until the White November Crisis of 1957. After the downfall of the Ministry, the Cryrian Government began to gradually shut the program down until it had been entirely dismantled in 1960.
The CDF disclosed a sizable stockpile of weaponized biological agents ranging from anthrax, plague, tularemia, glanders, brucellosis, Q-fever, botulinum, and orthopoxviruses such as smallpox.
 
The CDF disclosed a sizable stockpile of weaponized biological agents ranging from anthrax, plague, tularemia, glanders, brucellosis, Q-fever, botulinum, and orthopoxviruses such as smallpox along with established production lines. Limited samples are retained today under heavy restrictions for testing and research purposes. Some facilities in SIggeholm also remain active for similar purposes, and tightly controlled by the Special Materials Division.
 
==Major Installations==
verified
1,611

edits

Cookies help us deliver our services. By using our services, you agree to our use of cookies.

Navigation menu